Anthem Cellutions ( India) Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 09-05-2024
- Paid Up Capital ₹ 13.13 Cr
as on 09-05-2024
- Company Age 33 Year, 1 Month
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 75.91 Cr
as on 09-05-2024
- Revenue -10.53%
(FY 2017)
- Profit -28.87%
(FY 2017)
- Ebitda -28.65%
(FY 2017)
- Net Worth 6.59%
(FY 2017)
- Total Assets -8.37%
(FY 2017)
About Anthem Cellutions ( India)
- CIN/LLPIN
U85110KA1991PTC012478
- Company No.
012478
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 1991
- Date of AGM
28 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Anthem Cellutions ( India)?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Bhardwaj  | Managing Director | 09-Nov-2006 | Current |
| Divya Prasad | Company Secretary | 01-Dec-2015 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Sambasivam | Director | 09-Nov-2006 | Current |
| K Chandrappa | Director | 09-Nov-2006 | Current |
Financial Performance and Corporate Structure Insights of Anthem Cellutions ( India).
Anthem Cellutions ( India) Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 10.53% decrease. The company also saw a substantial fall in profitability, with a 28.87% decrease in profit. The company's net worth moved up by a moderate rise of 6.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anthem Cellutions ( India)?
In 2017, Anthem Cellutions ( India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anthem Biosciences Private LimitedActive 18 years 6 monthsAjay Bhardwaj, Ganesh Sambasivam and 2 more are mutual person
- Neoanthem Lifesciences Private LimitedActive 4 years 5 months
Ajay Bhardwaj, Ganesh Sambasivam and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 Aug 2010 | ₹13.00 Cr | Satisfied |
Corporation Bank Creation Date: 24 Apr 2009 | ₹1.00 Cr | Satisfied |
State Bank Of India Creation Date: 12 Oct 2007 | ₹54.38 Cr | Satisfied |
How Many Employees Work at Anthem Cellutions ( India)?
Unlock and access historical data on people associated with Anthem Cellutions ( India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anthem Cellutions ( India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anthem Cellutions ( India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
